A new class of sleep medicines, could provide relief for people living with insomnia, but pharmaceutical companies are struggling to bring them to the market.
Despite the rise of resistant infections, national figures show that antibiotic use continues to grow in hospitals. However, some trusts in England are stepping up their stewardship efforts and achieving significant reductions. Here, three trusts share the secrets to their success.
A closer look at the progress made so far on introducing a nationwide foundation training scheme.
‘Urgent action’ needed on pharmacist shortagesSubscription
NHS workforce planners warn that they are running out of pharmacists as demand for the profession rises.
With almost 1,400 reports of controlled drugs being lost, stolen or missing in 2018/2019, there are concerns regarding the increasing sophistication of those trying to subvert the system.
One year since UK law changed to enable medical cannabis to be prescribed, researchers are exploring the drug’s potential for treating post-traumatic stress disorder, schizophrenia and attention deficit hyperactivity disorder.
As the prevalence of sexually transmitted infections continues to rise and sexual health services remain under financial strain, pharmacists are increasingly being called upon to do more to bridge the gap.
The government’s latest scheme to tackle thinly stretched NHS services is set to launch on 29 October 2019, and it places community pharmacy at its core.
Communication between hospital and community pharmacists when patients are discharged is often absent, which can have a detrimental impact on patients’ health. The transfers of care around medicines — or ‘TCAM’ — scheme is beginning to change this, but there are several obstacles to overcome.
Not all pharmacists are convinced by the government’s claims that it is ready to leave the EU without a deal in place.
Power of one: what is holding polypills back?Subscription
Single pills with fixed-dose combinations of several medicines are not commonplace for the treatment of cardiovascular disease. As the first randomised controlled trial to show a polypill can cut the risk of heart attacks is published, we look at why, nearly two decades after it was first proposed, development and uptake is limited.
Binning the sharps: the quest for oral insulinSubscription
The pharmaceutical industry has been trying to develop oral formulations of insulin since the 1920s without success, but, over the past few years, several new oral delivery systems have shown promise in clinical trials.
A summary of the main points of the new contract that community pharmacists in England need to know about before October 2019.
Combinations of drugs involving anticoagulants are one of the most frequent causes of medicine-related hospital admissions, but pharmacists can help reduce the risk.
Recent regulatory breaches at drug manufacturing sites in India and China have raised questions about whether the UK needs to repatriate production of critical medicines.
Some hospital trusts are making progress towards replacing paper prescriptions with their electronic counterparts, but others are yet to make the switch. Here are ten tips for successful implementation of electronic prescribing and medicines administration systems.
The evolution of NHS 111Subscription
First piloted in 2011, the NHS 111 service is constantly evolving and pharmacists are being increasingly recognised for the role they can have within it. Although models across England, Scotland and Wales share the same general objectives, they have developed separately, resulting in different versions of the service with different visions for its future.
The supervision debate has been an ongoing point of contention for several years, but what exactly is the debate about and why is it so controversial?
Despite lagging behind their distance-selling counterparts in online dispensing, the digital revolution in community pharmacy may still be led by the top four high street pharmacy chains.
NHS England has set an ambitious target to be paperless by 2024, a major part of which is implementing electronic prescribing and medicines administration systems in hospitals. Although progress is being made, there remain challenges to overcome.
From controversial marketing campaigns to fears that its vast dispensing facilities will quash high street pharmacy businesses, Pharmacy2U’s rise has not gone unnoticed.
As the number of antibiotics supplied through the NHS Urgent Medicine Supply Advanced Service increases, concerns are growing over its impact on antimicrobial resistance.
Medical cannabis was legalised in the UK on 1 November 2018, but the regulations around its use and supply remain strict. Here is a quick update about how it is being used in the NHS and what benefits it may or may not offer.
Is a complete ban on OTC opioids the solution?Subscription
Misuse of over-the-counter opioids often slips under the radar. Some experts say the UK should follow other countries and ban them altogether, but others argue that there is more that pharmacists can do to help tackle this problem.
As concerns over deaths related to the diet pill 2,4-dinitrophenol (DNP) increase, healthcare professionals — including pharmacists — are being called on to play their part in raising awareness and preventing DNP-related harm.
An update on what pharmacists can expect from primary care networks, the latest revolution planned by NHS England.
In a move that has taken the sector by surprise, NHS trusts and pharmacy multiples have published plans to introduce a new route into the pharmacy profession via an apprenticeship scheme
Pharmacists can help patients with type 2 diabetes mellitus adopt a low-carbohydrate diet and reduce their medicines load.
The use of fish oils to improve cardiovascular health has been in and out of favour for decades, but positive results from a recent trial of Amarin’s Vascepa have created quite a stir — particularly as they come after a set of negative findings in 2018.
Will pharmacy become a five-year degree?Subscription
Proposals from the General Pharmaceutical Council to overhaul pharmacy education and training have been met with a mixed response.